Patents/Assignees

Amal Therapeutics SA

5 patents in portfolio

US12453762utility2025
Complex Comprising a Cell Penetrating Peptide, a Cargo and a TLR Peptide Agonist for Treatment of Glioblastoma
0 cites
US12220387utility2025
Fusion Comprising a Cell Penetrating Peptide, a Multi Epitope and a TLR Peptide Agonist for Treatment of Cancer
0 cites
US12220450utility2025
Complex Comprising a Cell Penetrating Peptide, a Cargo and a TLR Peptide Agonist for Treatment of Colorectal Cancer
0 cites
US12214048utility2025
Combination of an Immune Checkpoint Modulator and a Complex Comprising a Cell Penetrating Peptide, a Cargo and a TLR Peptide Agonist for Use in Medicine
0 cites
US12178788utility2024
Complex Comprising a Cell Penetrating Peptide, a Cargo and a TLR Peptide Agonist
0 cites